Dcaf13-KO Mouse
一般名
Dcaf13-KO
製品ID
S-KO-05693
背景情報
C57BL/6JCya
系統ID
KOCMP-223499-Dcaf13-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Dcaf13-KO Mouse(カタログ番号S-KO-05693)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Dcaf13-KO
系統ID
KOCMP-223499-Dcaf13-B6J-VA
遺伝子名
製品ID
S-KO-05693
遺伝子別名
Gm83, Wdsof1
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 15
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000022909
NCBIトランスクリプトID
NM_198606
ターゲット領域
Exon 2~6
有効領域の大きさ
~9.8 kb
遺伝子研究の概要
DCAF13, short for DDB1 and CUL4 associated factor 13, is a substrate receptor of the E3 ubiquitin ligase CRL4. It is involved in ubiquitination processes, which play crucial roles in regulating protein stability, function, and degradation, thus impacting various biological pathways and cellular functions [1,2,3,4]. Ubiquitination is essential for normal regulation of many biological functions such as cell cycle progression, DNA damage repair, and embryo development [4,5].
In disease-related research, DCAF13 has been found to be highly expressed in lung adenocarcinoma, ovarian cancer, and breast cancer, promoting cancer progression. In lung adenocarcinoma, it inhibits the p53 signaling pathway by promoting p53 ubiquitination and degradation, thus facilitating cancer cell proliferation and migration [1]. In ovarian cancer, it activates the FRAS1-mediated FAK signaling pathway by targeting FRAS1 for polyubiquitination and proteasomal degradation [2]. In breast cancer, it promotes cell proliferation by ubiquitin-inhibiting PERP expression [4]. Additionally, in preeclampsia, abnormal expression of DCAF13 affects endometrial decidualization, which may be involved in the occurrence and development of this pregnancy-related disorder [6]. In terms of embryo development, knockdown of DCAF13 in porcine embryos decreased blastocyst-stage development, affecting histone methylation-related gene expression and DNA damage repair [5]. In mice, uterine decidualization failed in pseudopregnant conditional Dcaf13 knockout mice, indicating its key role in decidualization [6]. Maternal-specific deletion of DCAF13 in mouse oocytes led to abnormal chromatin condensation and transcription in zygotic embryos, arresting development at the two-cell stage [7].
In summary, DCAF13 is essential for multiple biological processes, with its dysregulation contributing to various diseases. Gene knockout and conditional knockout mouse models have been pivotal in revealing its roles in cancer progression, embryo development, and preeclampsia, providing insights into potential therapeutic targets and disease mechanisms.
References:
1. Wei, Shan, Xing, Jing, Chen, Jia, Wang, Kai, Yu, Wanjun. 2024. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma. In Journal of experimental & clinical cancer research : CR, 43, 3. doi:10.1186/s13046-023-02936-2. https://pubmed.ncbi.nlm.nih.gov/38163876/
2. Tang, Ze-Yi, Wang, Xiao-Min, Xu, Chun-Wei, Cheng, Shu-Qun, Pan, Wei-Wei. 2024. DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway. In Cellular and molecular life sciences : CMLS, 81, 421. doi:10.1007/s00018-024-05446-2. https://pubmed.ncbi.nlm.nih.gov/39367995/
3. Ren, Peipei, Tong, Xiaomei, Li, Junjian, Zhang, Songying, Zhang, Yin-Li. 2024. CRL4DCAF13 E3 ubiquitin ligase targets MeCP2 for degradation to prevent DNA hypermethylation and ensure normal transcription in growing oocytes. In Cellular and molecular life sciences : CMLS, 81, 165. doi:10.1007/s00018-024-05185-4. https://pubmed.ncbi.nlm.nih.gov/38578457/
4. Shan, Bao-Qian, Wang, Xiao-Min, Zheng, Li, Pan, Wei-Wei, Zhang, Xin. 2022. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression. In Cancer science, 113, 1587-1600. doi:10.1111/cas.15300. https://pubmed.ncbi.nlm.nih.gov/35178836/
5. da Silva, Zigomar, Glanzner, Werner Giehl, Gutierrez, Karina, Gonçalves, Paulo Bayard Dias, Bordignon, Vilceu. 2023. DCAF13 and RNF114 participate in the regulation of early porcine embryo development. In Reproduction (Cambridge, England), 166, 401-410. doi:10.1530/REP-23-0230. https://pubmed.ncbi.nlm.nih.gov/37855431/
6. Yan, Xingyu, Rong, Miaomiao, Zhou, Qianhui, Zhang, Cong. 2022. DCAF13 is essential for the pathogenesis of preeclampsia through its involvement in endometrial decidualization. In Molecular and cellular endocrinology, 556, 111741. doi:10.1016/j.mce.2022.111741. https://pubmed.ncbi.nlm.nih.gov/35932979/
7. Liu, Yang, Zhao, Long-Wen, Shen, Jing-Ling, Fan, Heng-Yu, Jin, Yan. 2019. Maternal DCAF13 Regulates Chromatin Tightness to Contribute to Embryonic Development. In Scientific reports, 9, 6278. doi:10.1038/s41598-019-42179-w. https://pubmed.ncbi.nlm.nih.gov/31000741/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
